[1]
R. DEB, A. NARWAT, and S. VERMA, “NEBULIZED BUDESONIDE AS ADD-ON TO STANDARD THERAPY IN CHILDREN AGED 5-14 YEARS WITH ACUTE EXACERBATION OF ASTHMA”, Int J Curr Pharm Sci, vol. 18, no. 2, pp. 138–142, Mar. 2026.